Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given lateAdriano Pellicelli, M. Angélico, Ilaria Lenci et al.|Digestive and Liver Disease|2014Cited by 103
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter StudiesRodolphe Thiébaut, Michael M. Lederman, Thérèse Croughs et al.|Clinical Infectious Diseases|2016Cited by 80